These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Stroke and depression]. Sivolap YP; Damulin IV Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(9):143-147. PubMed ID: 31626232 [TBL] [Abstract][Full Text] [Related]
8. [Clinical significance and possibilities of therapy of post-stroke depression]. Trusova NA; Levin OS Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(9. Vyp. 2):60-67. PubMed ID: 31825392 [TBL] [Abstract][Full Text] [Related]
9. A Chinese Classical Prescription Chaihu Shugan Powder in Treatment of Post-Stroke Depression: An Overview. Gao Z; Wang Y; Yu H Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676679 [TBL] [Abstract][Full Text] [Related]
11. Empirically Supported Use of Psychiatric Medications in Adolescents and Adults with IBD. Thorkelson G; Bielefeldt K; Szigethy E Inflamm Bowel Dis; 2016 Jun; 22(6):1509-22. PubMed ID: 27167571 [TBL] [Abstract][Full Text] [Related]
12. Effects of selective serotonin reuptake inhibitors versus tricyclic antidepressants on cerebrovascular events: a nationwide population-based cohort study. Lee YC; Lin CH; Lin MS; Lin JW; Chang CH; Lai MS J Clin Psychopharmacol; 2013 Dec; 33(6):782-9. PubMed ID: 24091857 [TBL] [Abstract][Full Text] [Related]
13. A comprehensive overview of post-stroke depression treatment options. Raggi A; Serretti A; Ferri R Int Clin Psychopharmacol; 2024 May; 39(3):127-138. PubMed ID: 38170802 [TBL] [Abstract][Full Text] [Related]
14. Tricyclic Antidepressants and Monoamine Oxidase Inhibitors: Are They Too Old for a New Look? Chockalingam R; Gott BM; Conway CR Handb Exp Pharmacol; 2019; 250():37-48. PubMed ID: 30105472 [TBL] [Abstract][Full Text] [Related]
15. Comparative study of cognitive impairment between medicated and medication-free patients with remitted major depression: class-specific influence by tricyclic antidepressants and newer antidepressants. Nagane A; Baba H; Nakano Y; Maeshima H; Hukatsu M; Ozawa K; Suzuki T; Arai H Psychiatry Res; 2014 Aug; 218(1-2):101-5. PubMed ID: 24768252 [TBL] [Abstract][Full Text] [Related]
16. The impact of tricyclic antidepressants and selective serotonin re-uptake inhibitors on handwriting movements of patients with depression. Tucha O; Aschenbrenner S; Eichhammer P; Putzhammer A; Sartor H; Klein HE; Lange KW Psychopharmacology (Berl); 2002 Jan; 159(2):211-5. PubMed ID: 11862351 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease. Pollok J; van Agteren JE; Carson-Chahhoud KV Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012346. PubMed ID: 30566235 [TBL] [Abstract][Full Text] [Related]
18. Antidepressant drugs: does it matter if they inhibit the reuptake of noradrenaline or serotonin? Eriksson E Acta Psychiatr Scand Suppl; 2000; 402():12-7. PubMed ID: 10901154 [TBL] [Abstract][Full Text] [Related]
19. In-hospital predictors of post-stroke depression for targeted initiation of Selective Serotonin Reuptake Inhibitors (SSRIs). Yi J; Lu J; Yang A; Marsh EB BMC Psychiatry; 2022 Nov; 22(1):722. PubMed ID: 36402974 [TBL] [Abstract][Full Text] [Related]
20. Tricyclic antidepressants and selective serotonin reuptake inhibitors but not anticonvulsants ameliorate pain, anxiety, and depression symptoms in an animal model of central post-stroke pain. Shyu BC; He AB; Yu YH; Huang ACW Mol Pain; 2021; 17():17448069211063351. PubMed ID: 34903115 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]